Previous close | 45.82 |
Open | 45.60 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 155.00 |
Expiry date | 2024-10-18 |
Day's range | 45.60 - 45.82 |
Contract range | N/A |
Volume | |
Open interest | 4 |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.